Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Phase I/II Trial: <br />Ixazomib, Pomalidomide, Dexamethasone in Relapsed/Refractory Multiple Myeloma <br />Initial Results<br /> Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Background Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Background Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Methods Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Slide 5 Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Slide 6 Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Slide 7 Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Adverse events Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Dose-limiting toxicities Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Conclusions Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Acknowledgments Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Acknowledgments Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting Slide 13 Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting DLT definition Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

Presented By Amrita Krishnan at 2016 ASCO Annual Meeting DLT definition Presented By Amrita Krishnan at 2016 ASCO Annual Meeting